2003
DOI: 10.1078/094471103322331395
|View full text |Cite
|
Sign up to set email alerts
|

Comparative efficacy of Keishi-bukuryo-gan and Pentoxifylline on RBC deformability in patients with “oketsu” syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
33
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(33 citation statements)
references
References 11 publications
0
33
0
Order By: Relevance
“…Keishibukuryogan is reported to improve the microcirculation of the bulbar conjunctiva, 9) to protect vasofunction in a model of diabetic rat, 10) to decrease atherosclerosis in a model of hypercholesterolemic rabbit, 11) and so on. Concerning the mechanisms of these vasoprotective effects, keishibukuryogan is reported to exert an improvement effect on hemorheological factors 9,12) as well as an anti-oxidant effect. 13) As part of this formula, Cinnamomi Cortex is thought to have various effects on anti-platelet aggregation, 5,6) inhibition of thromboxane A2, 14) to have a vasorelaxation effect, 7) and so on.…”
Section: Discussionmentioning
confidence: 99%
“…Keishibukuryogan is reported to improve the microcirculation of the bulbar conjunctiva, 9) to protect vasofunction in a model of diabetic rat, 10) to decrease atherosclerosis in a model of hypercholesterolemic rabbit, 11) and so on. Concerning the mechanisms of these vasoprotective effects, keishibukuryogan is reported to exert an improvement effect on hemorheological factors 9,12) as well as an anti-oxidant effect. 13) As part of this formula, Cinnamomi Cortex is thought to have various effects on anti-platelet aggregation, 5,6) inhibition of thromboxane A2, 14) to have a vasorelaxation effect, 7) and so on.…”
Section: Discussionmentioning
confidence: 99%
“…One of the causes of Oketsu is insufficiency of microcirculation in modern medicine. 23) Keishibukuryogan has been reported to improve blood circulation and vasoendothelial disorders in animal models of diabetes and hypertension. 5,6,24,25) The mechanism for this improvement by keishibukuryogan was an anti-oxidative effect on microcirculation.…”
Section: Discussionmentioning
confidence: 99%
“…The impacts of keishibukuryogan on the laboratory parameters of coagulation system are shown in reports on shortened PT in disseminated intravascular coagulation (DIC) model rats, 26) shortened PT in patients taking warfarin, 27) and increased D-dimer in patients having received knee replacement surgery. 20) On the other hand, reports on blood coagulation factors in patients receiving keishibukuryogan described decreased fibrinogen in patients with lacunar infarct, 18) improved reduction of thrombotest results and AT-III activity in rats with high blood viscosity, 28) improved reduction of fibrinogen and platelet in DIC model rats. 26) These reports will lead to an assumption that the effects of keishibukuryogan on the coagulation system vary according to the conditions, and these effects will help correct an unbalanced status by exerting impacts both on coagulation and fibrinolysis.…”
Section: Discussionmentioning
confidence: 99%
“…The studies on the effect of keishibukuryogan for sensory disturbance include that on arteriosclerosis obliterans of lower extremities reported by Yokokawa, et al 9) and that in patients with cerebral stroke reported by Fujita, et al 10) The authors of the both studies estimated that keishibukuryogan with its effects to promote blood fluidity and peripheral blood flow contributed to the alleviation of the subjective symptoms of the patients by improving coldness and numbness. Various effects of keishibukuryogan have so far been reported: decrease in blood viscosity, 11) dilation of arteries, 11) inhibition of platelet aggregation, 12,13) and promotion of erythrocyte deformability 14) in the field of basic pharmacology, and increase in blood flow rate, 15) decrease in blood viscosity, [15][16][17] inhibition of platelet aggregation, 17) inhibition of erythrocyte aggregation, 15) promotion of erythrocyte deformability, 18) and decrease in hematocrit level 15) in the field of clinical pharmacology. These factors may contribute to the effect of keishibukuryogan to increase peripheral blood flow.…”
Section: Skin Perfusion Pressure (Spp)mentioning
confidence: 99%